Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.

about

Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.

Item

http://www.wikidata.org/entity/Q52573949

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Survival after recurrence in p ...... analysis of the ACTS-GC trial.

@en

Survival after recurrence in p ...... analysis of the ACTS-GC trial.

@nl

type

Item

label

Survival after recurrence in p ...... analysis of the ACTS-GC trial.

@en

Survival after recurrence in p ...... analysis of the ACTS-GC trial.

@nl

prefLabel

Survival after recurrence in p ...... analysis of the ACTS-GC trial.

@en

Survival after recurrence in p ...... analysis of the ACTS-GC trial.

@nl

P1476

Survival after recurrence in p ...... analysis of the ACTS-GC trial

@en

P2093

Mitsuru Sasako

http://www.w3.org/2001/XMLSchema#string

Yasuo Ohashi

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised co

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

Optimal chemotherapy treatment for women with recurrent ovarian cancer

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

P2888

s12885-018-4341-6

P304

449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4341-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seiji Ito

P577

2018-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103481543

http://www.w3.org/2001/XMLSchema#string

P698

29678146

http://www.w3.org/2001/XMLSchema#string

P932

5910584

http://www.w3.org/2001/XMLSchema#string